InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,960.70
(
-1.01%
)
US TECH 100
16,573.80
(
-2.14%
)
Dow Jones
37,958.34
(
0.48%
)
Brent Oil
86.69
(
0.31%
)
Bitcoin
64,200.00
(
1.09%
)
Post# of 14851
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Just the facts maam

Send PM Follow Ignore
Followers 20
Posts 5321
Boards Moderated 0
Alias Born 01/04/2012

Just the facts maam

Re: None

Sunday, 09/17/2017 4:02:02 AM

Sunday, September 17, 2017 4:02:02 AM

Post# of 14851
If AbbVie intends to launch Libigel or what ever it will be called by Q4 of 2018, when Humira biosimilars are expected to go on sale in Europe, AbbVie should be submitting their Priority Review Voucher during Q4 of 2017. That is 90 days before a 6 month PDUFA date is given by the FDA.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ANIP News
More ANIP News
InvestorsHub NewsWire

VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM

Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM

ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM

Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM

Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM

Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM

Start posting your company's news
Only $200 per official company press release!